In NSCLC, CD3+ infiltrating T cells are the most prominent immune cell expressing VISTA, with CD8+ cytotoxic cells expressing more VISTA than CD4+ T regulatory lymphocytes (38). The gene discussed is CD4; the disease is non-small cell lung carcinoma.